DT&CRO CO., Ltd. (KOSDAQ:383930)
South Korea
· Delayed Price · Currency is KRW 2,865.00
+35.00 (1.24%)
At close: Mar 9, 2026
DT&CRO CO. Revenue
DT&CRO CO. had revenue of 12.57B KRW in the quarter ending September 30, 2025, with 19.56% growth. This brings the company's revenue in the last twelve months to 44.36B, up 76.73% year-over-year. In the year 2024, DT&CRO CO. had annual revenue of 35.97B with 35.30% growth.
Revenue (ttm)
44.36B
Revenue Growth
+76.73%
P/S Ratio
0.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.63B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WOOJUNG BIO | 37.12B |
| C&R Research | 63.97B |
| SLS BIO | 5.47B |
| P&K Skin Research Center | 22.13B |
| BioInfra | 21.92B |
| HLB bioStep | 71.47B |
| Curachem | 6.02B |
| DreamCIS | 62.06B |